S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
3 Clean Energy Stocks that Could Get Boosted by Biden
pixel
Why These 3 ETFs Should be in Your 2021 Portfolio
MarketBeat: Week in Review 1/18 - 1/22
Biden's pause on oil cause for big concern in New Mexico
Chipmaker Intel Corp. blames internal error on data leak
Biden ordering stopgap help as talks start on big aid plan
Biden's choice on econ aid: Deal with GOP or go for it all
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
3 Clean Energy Stocks that Could Get Boosted by Biden
pixel
Why These 3 ETFs Should be in Your 2021 Portfolio
MarketBeat: Week in Review 1/18 - 1/22
Biden's pause on oil cause for big concern in New Mexico
Chipmaker Intel Corp. blames internal error on data leak
Biden ordering stopgap help as talks start on big aid plan
Biden's choice on econ aid: Deal with GOP or go for it all
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
3 Clean Energy Stocks that Could Get Boosted by Biden
pixel
Why These 3 ETFs Should be in Your 2021 Portfolio
MarketBeat: Week in Review 1/18 - 1/22
Biden's pause on oil cause for big concern in New Mexico
Chipmaker Intel Corp. blames internal error on data leak
Biden ordering stopgap help as talks start on big aid plan
Biden's choice on econ aid: Deal with GOP or go for it all
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
3 Clean Energy Stocks that Could Get Boosted by Biden
pixel
Why These 3 ETFs Should be in Your 2021 Portfolio
MarketBeat: Week in Review 1/18 - 1/22
Biden's pause on oil cause for big concern in New Mexico
Chipmaker Intel Corp. blames internal error on data leak
Biden ordering stopgap help as talks start on big aid plan
Biden's choice on econ aid: Deal with GOP or go for it all
Log in
OTCMKTS:TNGN

(TNGN) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume10,000 shs
Average Volume6,051 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Tengion, Inc. is a medicine company, focuses on discovering, developing, manufacturing and commercializing of neo-organs and products. The company was founded by Steven Nichtberger and David I. Scheer on July 10, 2003 and is headquartered in Winston-Salem, NC.

MarketRank™

Overall MarketRank™

0.40 out of 5 stars

Health Technology Sector

18th out of 18 stocks

Biotechnology Industry

72nd out of 88 stocks

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Biotechnology
Sub-IndustryN/A
SectorHealth Technology
Current SymbolOTCMKTS:TNGN
Previous Symbol
CUSIPN/A
CIK1296391
Webwww.tengion.com
Phone(336) 722-5855
EmployeesN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive TNGN News and Ratings via Email

Sign-up to receive the latest news and ratings for TNGN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











(TNGN) (OTCMKTS:TNGN) Frequently Asked Questions

What stocks does MarketBeat like better than (TNGN)?

Wall Street analysts have given (TNGN) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but (TNGN) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of (TNGN)'s key competitors?

Some companies that are related to (TNGN) include (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), 138267 (COM.TO) (COM), 17031 (MYM), Abattis Bioceuticals (ATTBF), Abzena plc (ABZA.L) (ABZA), Acrux Limited (ACR.AX) (ACR), Actinogen Medical Limited (ACW.AX) (ACW), AdAlta Limited (1AD.AX) (1AD), ADiTx Therapeutics (ADTX), Admedus (AHZ), Alaric (HALB), Algernon Pharmaceuticals (AGNPF) and Almirall (LBTSF).
View all of TNGN's competitors.

Who are (TNGN)'s key executives?

(TNGN)'s management team includes the following people:
  • David I. Scheer, Independent Chairman of the Board (Age 63)
  • Carl-Johan Dalsgaard M.D., Independent Director (Age 56)
  • Diane K. Jorkasky M.D., Independent Director (Age 61)
  • Richard E. Kuntz M.D., Independent Director (Age 58)
  • Lorin Jeffry Randall, Independent Director

What is (TNGN)'s stock symbol?

(TNGN) trades on the OTCMKTS under the ticker symbol "TNGN."

How do I buy shares of (TNGN)?

Shares of TNGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is (TNGN)'s official website?

The official website for (TNGN) is www.tengion.com.

How can I contact (TNGN)?

(TNGN)'s mailing address is 3929 Westpoint Blvd Ste G, WINSTON SALEM, NC 27103-6761, United States. The company can be reached via phone at (336) 722-5855.

This page was last updated on 1/23/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.